Fluorescence‐ and bioluminescence‐based approaches to study GPCR ligand binding
Open Access
- 28 August 2015
- journal article
- review article
- Published by Wiley in British Journal of Pharmacology
- Vol. 173 (20), 3028-3037
- https://doi.org/10.1111/bph.13316
Abstract
Ligand binding is a vital component of any pharmacologist's toolbox and allows the detailed investigation of how a molecule binds to its receptor. These studies enable the experimental determination of binding affinity of labelled and unlabelled compounds through kinetic, saturation (Kd) and competition (Ki) binding assays. Traditionally, these studies have used molecules labelled with radioisotopes; however, more recently, fluorescent ligands have been developed for this purpose. This review will briefly cover receptor ligand binding theory and then discuss the use of fluorescent ligands with some of the different technologies currently employed to examine ligand binding. Fluorescent ligands can be used for direct measurement of receptor‐associated fluorescence using confocal microscopy and flow cytometry as well as in assays such as fluorescence polarization, where ligand binding is monitored by changes in the free rotation when a fluorescent ligand is bound to a receptor. Additionally, fluorescent ligands can act as donors or acceptors for fluorescence resonance energy transfer (FRET) with the development of assays based on FRET and time‐resolved FRET (TR‐FRET). Finally, we have recently developed a novel bioluminescence resonance energy transfer (BRET) ligand binding assay utilizing a small (19 kDa), super‐bright luciferase subunit (NanoLuc) from a deep sea shrimp. In combination with fluorescent ligands, measurement of RET now provides an array of methodologies to study ligand binding. While each method has its own advantages and drawbacks, binding studies using fluorescent ligands are now a viable alternative to the use of radioligands. Linked Articles This article is part of a themed section on Molecular Pharmacology of G Protein‐Coupled Receptors. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v173.20/issuetocKeywords
Funding Information
- Medical Research Council (G0800006)
- Australian Research Council (LP130100037)
This publication has 61 references indexed in Scilit:
- Adenosine‐A3 receptors in neutrophil microdomains promote the formation of bacteria‐tethering cytonemesEMBO Reports, 2013
- Fragment Screening at Adenosine-A3 Receptors in Living Cells Using a Fluorescence-Based Binding AssayCell Chemical Biology, 2012
- Engineered Luciferase Reporter from a Deep Sea Shrimp Utilizing a Novel Imidazopyrazinone SubstrateACS Chemical Biology, 2012
- Novel fluorescent antagonist as a molecular probe in A3 adenosine receptor binding assays using flow cytometryBiochemical Pharmacology, 2012
- Synthesis and Characterization of High-Affinity 4,4-Difluoro-4-bora-3a,4a-diaza-s-indacene-Labeled Fluorescent Ligands for Human β-AdrenoceptorsJournal of Medicinal Chemistry, 2011
- Fluorescence Polarization Screening for Allosteric Small Molecule Ligands of the Cholecystokinin ReceptorASSAY and Drug Development Technologies, 2011
- Allosteric interactions across native adenosine‐A 3 receptor homodimers: quantification using single‐cell ligand‐binding kineticsThe FASEB Journal, 2011
- Temporal Profiling of Orexin Receptor-Arrestin-Ubiquitin Complexes Reveals Differences between Receptor SubtypesOnline Journal of Public Health Informatics, 2011
- Novel Alexa Fluor-488 labeled antagonist of the A2A adenosine receptor: Application to a fluorescence polarization-based receptor binding assayBiochemical Pharmacology, 2010
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973